FIBROBIOLOGICS INC COM NEW

FIBROBIOLOGICS INC COM NEW is a security (CUSIP 31573L204) tracked across SEC portfolio filings. 15 institutional managers reported $274K on Form 13F as of 2026-06-30; 1 registered fund positions totaling $37K via N-PORT as of 2026-03-31.

Summary

Top institutional holders (Form 13F)

ManagerLocationValueShares
Cascade Financial Partners, LLCSAN DIEGO, CA$103K108,828
Fund Evaluation Group, LLCCINCINNATI, OH$68K51,794
GEODE CAPITAL MANAGEMENT, LLCBOSTON, MA$39K29,609
BlackRock, Inc.New York, NY$33K24,647
RENAISSANCE TECHNOLOGIES LLCNEW YORK, NY$21K15,997
UBS Group AGZurich, V8$8K5,721
NewEdge Advisors, LLCNew Orleans, LA$1K845
Tower Research Capital LLC (TRC)NEW YORK, NY$607460
ISLAY CAPITAL MANAGEMENT, LLCLubbock, TX$223169
OSAIC HOLDINGS, INC.PHOENIX, AZ$203154
Grove Bank & TrustMIAMI, FL$95100
BNP PARIBAS ARBITRAGE, SNCPARIS, I0$8766
Allworth Financial LPFOLSOM, CA$1813
WELLS FARGO & COMPANY/MNSAN FRANCISCO, CA$1310
Royal Bank of CanadaTORONTO, A6—186

Top fund holders (N-PORT)

FundRegistrantValue% of fund
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$37K0.00%

More